Injectable Cytotoxic Drugs Market Trends

• Shift from broad spectrum generic oncology drugs such as traditional injectable cytotoxic drugs to a more precise and targeted small molecule can be observed in the injectable cytotoxic drugs industry. Injectable cytotoxic drugs are increasingly being used in combination with targeted therapies to enhance treatment efficacy and overcome resistance mechanisms, particularly in cancers with actionable mutations or biomarkers.
  
• Furthermore, use of natural compounds derived from plants and marine organisms, as a potent sources for developing anticancer agents with cytotoxic properties such as Artemisinin has driven the significant investments from pharmaceutical companies. For instance, according to an article published by National Center for Biotechnology Information, by the end of 2022, there were 17 marine derived drugs approved for clinical use, out of these, about 71% were approved for the treatment of various cancer types.